Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Publication year range
1.
Gan To Kagaku Ryoho ; 33(8): 1159-62, 2006 Aug.
Article in Japanese | MEDLINE | ID: mdl-16912540

ABSTRACT

We report a case in which combination chemotherapy of TS-1 and paclitaxel was effective for gastric cancer with malignant ascites, metastatic ovarian cancer and hydronephrosis. Judging from the above issue, the stage was IV and the type was Borrmann 4. The chemotherapy schedule was adjusted at the patient' s request without hindering her activities of daily living. The patient was a 53-year-old woman who suffered from gastric cancer as having malignant ascites and metastatic ovarian tumor. As an outpatient, she was treated with combination chemotherapy of TS-1 and paclitaxel for 2 cycles. The ascites had remarkably disappeared after 2 cycles. The adverse event was alopecia (grade 2), but she could continue the chemotherapy as an outpatient treatment. After completing 5 cycles of chemotherapy, we recognized the primary tumor as an endoscopic complete response.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Carcinoma, Signet Ring Cell/drug therapy , Stomach Neoplasms/drug therapy , Alopecia/chemically induced , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Carcinoma, Signet Ring Cell/secondary , Drug Administration Schedule , Drug Combinations , Female , Humans , Middle Aged , Ovarian Neoplasms/secondary , Oxonic Acid/administration & dosage , Oxonic Acid/adverse effects , Paclitaxel/administration & dosage , Paclitaxel/adverse effects , Quality of Life , Remission Induction , Stomach Neoplasms/pathology , Tegafur/administration & dosage , Tegafur/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL
...